NCT00453674 German Adrenocortical Carcinoma Registry
| NCT ID | NCT00453674 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Wuerzburg |
| Condition | Adrenocortical Carcinoma |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2003-01 |
| Primary Completion | 2030-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2003-01 with a primary completion date of 2030-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Basic objective of the German Adrenocortical Carcinoma Registry is to improve the care of patients with adrenocortical cancer. The registration of as many patients as possible helps to collect data for the prognosis and prospects of success regarding different treatment plans. This data will be taken into consideration for planning prospective studies. With this registry, the recruitment of patients for prospective studies will be significantly facilitated. In this way - and in cooperation with networks in other countries (e.g. in Italy and France) - a structure allowing systematic improvement of therapy will be developed.
Eligibility Criteria
Inclusion Criteria: * Histologically confirmed diagnosis of adrenocortical carcinoma
Contact & Investigator
Martin Fassnacht, MD
PRINCIPAL INVESTIGATOR
University of Wuerzburg
Frequently Asked Questions
Who can join the NCT00453674 clinical trial?
This trial is open to participants of all sexes, studying Adrenocortical Carcinoma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT00453674 currently recruiting?
Yes, NCT00453674 is actively recruiting participants. Contact the research team at fassnacht_m@medizin.uni-wuerzburg.de for enrollment information.
Where is the NCT00453674 trial being conducted?
This trial is being conducted at Würzburg, Germany.
Who is sponsoring the NCT00453674 clinical trial?
NCT00453674 is sponsored by University of Wuerzburg. The principal investigator is Martin Fassnacht, MD at University of Wuerzburg. The trial plans to enroll 1,000 participants.